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SUMMARY
In this case-control study, we investigated the seroprevalence and molecular evidence of
Chlamydia trachomatis and Waddlia chondrophila in ectopic pregnancies (EP) and uneventful
control pregnancies in 343 women from Vietnam. Whereas presence of C. trachomatis IgG was
strongly associated with EP [adjusted odds ratio (aOR) 5·41, 95% conﬁdence interval (CI)
2·58–11·32], its DNA remained undetected in all tubal lesions. We conﬁrmed an independent
association between antibodies against Waddlia and previous miscarriage (aOR 1·87, 95% CI
1·02–3·42). Further investigations are needed to understand the clinical signiﬁcance of Waddlia’s
high seroprevalence (25·9% in control pregnancies) in this urban population.
Key words: Adverse pregnancy outcome, Chlamydia-related bacteria, ectopic pregnancy, genital
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Chlamydiae are obligate intracellular bacteria belonging
to the order Chlamydiales [1]. Chlamydia trachomatis is
themost commonbacterial cause of sexually transmitted
infectionsworldwide [2]. Inwomen, 90%ofC. trachoma-
tis infections remain asymptomatic. However, if left
untreated, chlamydial infection can lead to scarring of
uterine tubes, pelvic inﬂammatory disease (PID), ectopic
pregnancy (EP) and adverse pregnancy outcomes [2, 3].
C. trachomatis induced pathogenesis is largely a result
of chronic immunopathological reactions, most likely
caused by persistent infections [3].
Waddlia chondrophila, a Chlamydia-related bac-
terium, has recently been associated with both animal
and human adverse pregnancy outcomes, such as mis-
carriage [2, 4–6]. Its mode of transmission and patho-
genesis remains to be explored.
Since several Chlamydia spp. and Chlamydia-related
bacteria colonize the cervico-vaginal mucosa [5–7],
which may lead to tubal scarring and have been asso-
ciated with adverse pregnancy outcomes in humans, we
thus investigated their role in EPs. EP, a condition in
which a fertilized egg settles and grows in a location
other than the inner lining of the uterus, occurs in 2% of
all pregnancies and remains the leading cause of preg-
nancy-relateddeath in theﬁrst trimester of gestation [8, 9].
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A total of 343 patients were recruited at Tu Du
Hospital, Hô Chi Minh City (Vietnam). The EP group
included 177 women with an EP treated by laparoscopic
salpingectomy. The control group included 166 women
without any history of previous EP andwho experienced
anuneventful pregnancy. Blood samples, fallopian tubes
or placental biopsies were collected for each EP and
control patient. Local ethical committees of both hospi-
tals (clinical part in Vietnam and experimental part in
Switzerland) approved the study protocol and all
patients included in the study gave their written consent.
Serological status and epidemiological data were
compared between patients with and without EPs, or
between patients with and without Waddlia-positive
serology by Pearson’s χ2 test (or Fisher’s exact test
when indicated) for categorical variables. For continu-
ous variables, medians were compared by the
Wilcoxon–Mann–Whitney test. Multivariate logistic
regressions were performed to identify factors inde-
pendently associated with EPs and miscarriages. All
statistical analyses were performed using Stata
v. 13.0 (StataCorp., USA).
Sociodemographical data are presented in Table 1.
All sera were tested for antibodies against C. tracho-
matis (Table 1), as described previously [1, 4, 6, 7,
10, 11]. C. trachomatis IgG seroprevalence was 6·6%
in the present Asian control population. Similar
prevalence has been described by other studies [7, 12, 13].
C. trachomatis seroprevalence was higher for women
who experienced an EP (24·9%) than for women with
an uneventful pregnancy (6·6%, P < 0·001).
For Waddlia and other Chlamydia-related bacteria
microimmunoﬂuorescence (MIF) tests were per-
formed as described previously [1, 4, 6]. All immu-
noﬂuorescence samples were read by two
independent observers and only congruent results
were considered positive. Sera that exhibited total
immunoglobulin (Ig) titre 51:64 were tested for IgG
and IgM reactivity using corresponding anti-human
Fluorescein-labelled Ig (FluolineG or FluolineM,
bioMérieux, France) and serial twofold dilutions of
sera. Waddlia IgG and IgM positivity cut-offs were
51:64 and 51:32, respectively [1]. There was a sign-
iﬁcant association between total anti-Waddlia anti-
bodies detected by MIF and EP (P = 0·04).
However, there was no statistical association with
EP when anti-Waddlia IgG, or anti-Waddlia IgM,
were considered. Waddlia ELISA was performed
as described previously [14] and conﬁrmed the
association between Waddlia seropositivity and EP
(P = 0·046). Serological evidence of human exposure
to other Chlamydia-related bacteria, such as
Parachlamydia acanthamoebae, Estrella lausannensis
and Criblamydia sequanensis were not associated
Table 1. Sociodemographical data and serologies according to pregnancy outcome
Characteristics Control (n= 166) Ectopic pregnancy (n= 177) P value
Age, years (±S.D.) 28 ± 5·2 30·3 ± 6·4 0·0 003
540 years 6 (3·6%) 17 (9·6%) 0·031
Nulliparity 111 (66·9%) 72 (40·7%) <0·001
Comorbidity 19 (11·5%) 7 (4%) 0·013
Pets at home 53 (31·93%) 54 (30·51%) 0·777
Lifetime sexual partners (52) 2 (1·2%) 12 (6·8%) 0·012
Chlamydia trachomatis ELISA*
Negative 153 (92·2%) 126 (71.2%) <0·0 001
Positive 11 (6·6%) 44 (24.9%)
Doubtful† 2 (1·2%) 7 (4%)
Waddlia MIF
Total Ig51/64 49 (29·5%) 71 (40.1%) 0·04
IgG51/64 43 (25·9%) 57 (32.2%) 0·2
IgM51/32 2 (1·2%) 3 (1.7%) 1
Waddlia ELISA OD 0·35 ± 0·097 0·371 ± 0·092 0·046
Parachlamydia IgG MIF 10 (6·0%) 19 (10.7%) 0·125
Estrella IgG MIF 21 (12·7%) 35 (19.8%) 0·081
Criblamydia MIF 4 (2·4%) 5 (2.8%) 1·0
MIF, Microimmunoﬂuorescence; OD, optical density.
*MOMP-R, CT pELISA (R-Biopharm, Germany)
† Similar P values when doubtful were excluded.
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with EP (Table 1). Whenall variables fromTable1were
considered (stepwise logistic regression analysis), the
only three independent factors associated with EP were
a positive C. trachomatis serology [adjusted odds ratio
(aOR) 5·41, 95% conﬁdence interval (CI) 2·58–11·31],
number of sexual partners (aOR 9·34, 95% CI 1·95–
44·66) and parity (aOR 2·69, 95% CI 1·94–3·75), which
arewell known risk factors for EP [8, 9]. Patients’ charac-
teristics according to their C. trachomatis serological
status are given in Supplementary Table S1.
Women seropositive for Waddlia (n= 100, 29·2%)
were older (P = 0·007) and experienced previous mis-
carriages more frequently (P = 0·005) than Waddlia-
negative women (Table 2). The association between
Waddlia seropositivity and miscarriage remained sign-
iﬁcant (aOR 1·87, 95% CI 1·02–3·42) even after ad-
justment for age, parity, comorbidity and other
serologies including C. trachomatis. There was no stat-
istical association between Waddlia-positive serology
and medical comorbidities, gynaecological complaints
during pregnancy, work status, number of lifetime
sexual partners or presence of pets at home.
There was no cross-reaction between Waddlia and
C. trachomatis serologies, since 77 patients (23·1%)
were positive only for Waddlia IgG and 37 (11·1%)
were positive only for C. trachomatis IgG (Table 2).
Only 18 patient (5·4%) were positive for both bacteria
(P = 0·513).
Presence of Waddlia [15, 16] and/or C. trachomatis
[7] DNA was tested in IgG-positive patients. DNA ex-
traction was performed from a 2-cm piece of fallopian
tube (EP) or placental (C) tissue using Wizard SV
genomic DNA puriﬁcation kit (Promega Cor-
poration, USA), and a pan-Chlamydiales PCR was
performed as described previously [17]. This
Pan-Chlamydiales PCR is able to detect up to ﬁve
DNA copies per reaction and demonstrated similar
performance compared to speciﬁc Chlamydiales
PCRs. Neither the 50 fallopian tubes nor the 43
placental samples with a positive Waddlia and/or
C. trachomatis serology were positive for Waddlia or
C. trachomatis DNA. All 20 control patients with a
negative serology (10 from the ‘EP’ group and
10 from the ‘C’ group) were also negative by PCR.
In summary, our data showed a strong association
between C. trachomatis seropositivity and EP.
However, neither the fallopian tubes nor placenta of
women with positive Chlamydia orWaddlia serologies
demonstrated presence of respective bacteria, which
has also been shown by others [12]. Moreover, IgG
but not IgM antibodies were detected during EPs.
Thus, these results suggest that the persistence of the
bacteria is not necessary to induce tubal damage,
and reinforces the role of an immunopathological pro-
cess due to a previous chlamydial infection [18, 19].
However, the physiopathology mechanism by which
tubal scarring occurs without the presence of bacteria
is not yet fully understood [12, 19].
Waddlia IgG seroprevalence in the control group
(25·9%) was higher than previously described in
other asymptomatic patients: 14·6% in Switzerland
[6], and 7·1% in London [4]. This difference could be
explained as a result of higher genetic susceptibility
of the Vietnamese population to Waddlia infection
or greater exposure to the yet unknown source of
Waddlia infection [2, 4, 6].
Whereas our study only identiﬁed a limited associ-
ation of Waddlia with EP (P = 0·04), we observed a
strong correlation between previous history of miscar-
riage and positive Waddlia serology (P = 0·005). This
Table 2. Patient`s characteristics according to their Waddlia serological status
Characteristics
Waddlia IgG
negative (n= 243)
Waddlia IgG
positive (n= 100) P value
Age, years (±S.D.) 28·7 ± 5·7 30·3 ± 6·3 0·02
540 years 10 (4·1%) 13 (13%) 0·007
Nulliparity 137 (56·4%) 46 (46%) 0·08
Previous miscarriage 34 (14%) 24 (24%) 0·005
Comorbidity 18 (7·4%) 7 (7%) 1
Pets at home 166 (68·31%) 70 (70%) 0·759
Lifetime sexual partners (52) 11 (4·5%) 3 (3%) 0·765
Chlamydia trachomatis ELISA 37 (15·2%) 18 (18%) 0·513
Parachlamydia IgG MIF 19 (7·8%) 10 (10%) 0·525
Estrella IgG MIF 38 (15·6%) 18 (18%) 0·63
Criblamydia MIF 5 (2·1%) 4 (4%) 0·292
MIF, Microimmunoﬂuorescence.
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was expected since Waddlia was previously reported
as an abortigenic agent in both animal and human
populations [2, 4–6, 19].
A major limitation of the study was the absence of
data concerning other potential confounding factors
for EP (i.e. other infectious agents) and miscarriage
(i.e. chromosomal anomalies).
In conclusion, this study conﬁrmed the serological as-
sociation of C. trachomatis with EP [8] and of Waddlia
with miscarriage [4, 6]. Moreover, we showed an associ-
ation between anti-Waddlia antibodies and EP using
both immunoﬂuorescence and ELISA. Absence of C.
trachomatis andW. chondrophila DNA in the fallopian
tubes or placental tissues suggests that immunopatholo-
gical mechanisms rather than bacterial infection are
involved in EP. Further investigations are needed to
understand the high prevalence of Waddlia in this
Asian population and to precise its role in EP.
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